Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309749 · ClinicalTrials.gov registry record
CAP Pilot Study for Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- 50
- Enrollment target
NCT02309749: Completed study, sponsored by Fisher and Paykel Healthcare.
NCT02309749 is a clinical trial that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02309749 has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.
Primary Outcome
Cross check recieved messages logged in a diary by the participant to those sent by CAP
Interventions
- OTHER CAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12 |
What the finished NCT02309749 record still lists
NCT02309749 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CAP is the first listed.
NCT02309749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02309749 about?
NCT02309749 is a clinical study titled "CAP Pilot Study for Obstructive Sleep Apnea (OSA)". This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours pe...
What is the current status of trial NCT02309749?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02309749?
The interventions under investigation include: CAP (OTHER).
Who is sponsoring clinical trial NCT02309749?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia